# Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.

> **NCT07703748** · — · ACTIVE_NOT_RECRUITING · sponsor: **FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE** · enrollment: 3346 (actual)

## Conditions studied

- Human Immunodeficiency Virus Infection (HIV)
- HIV-1 Infection in Adults

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07703748
- **Lead sponsor:** FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-31
- **Primary completion:** 2029-04-30
- **Final completion:** 2029-04-30
- **Target enrollment:** 3346 (ACTUAL)
- **Last updated:** 2026-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703748, "Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07703748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*